Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
27.16
+0.05 (0.17%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Alkermes Employees
Alkermes had 1,800 employees as of December 31, 2024. The number of employees decreased by 300 or -14.29% compared to the previous year.
Employees
1,800
Change (1Y)
-300
Growth (1Y)
-14.29%
Revenue / Employee
$865,351
Profits / Employee
$203,928
Market Cap
4.48B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
ALKS News
- 6 days ago - Alkermes to Report First Quarter Financial Results on May 1, 2025 - PRNewsWire
- 21 days ago - Alkermes to Participate in the 24th Annual Needham Virtual Healthcare Conference - PRNewsWire
- 22 days ago - Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia - PRNewsWire
- 27 days ago - New National Survey of Healthcare Providers Offers Insights Into the Dynamic and Challenging Treatment Journey for People Living With Schizophrenia or Bipolar I Disorder - PRNewsWire
- 2 months ago - Alkermes to Participate in Upcoming Investor Conferences - PRNewsWire
- 2 months ago - Alkermes' Neuroscience Pivot: ALKS 2680 Set To Revolutionize Narcolepsy Treatment - Seeking Alpha
- 2 months ago - Alkermes plc (ALKS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2024 and Provides Financial Expectations for 2025 - PRNewsWire